The Ryan White HIV/AIDS Program: The Basics
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
Read More
Senate Finance Language Would Further Cut Federal Spending for Medicaid Expansion States
Prior KFF analysis allocated CBO’s federal Medicaid spending reductions and enrollment losses across the states, and this policy watch builds on that analysis to examine the potential impacts in expansion states compared with non-expansion states.
Cohere Health Snags $90M to Automate the Much-Maligned Prior Authorization Process
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners. The post Cohere Health Snags $90M to Automate the Much-Maligned…
The Future of Men’s Healthcare: A Path to Improved Access, Outcomes, and Cost Savings
Telehealth empowers men to take control of their health in a way that is easy, confidential, and fits into their busy lifestyles. The post The Future of Men’s Healthcare: A Path to Improved Access, Outcomes, and Cost Savings appeared first on MedCity News.
COVID Vaccine Concerns and Claims About Ivermectin as Cancer Treatment — The Monitor
This volume covers recent claims about COVID vaccine safety after a new study describes a rare condition it calls “post-vaccination syndrome” (PVS). It also investigates the false claim that ivermectin can treat cancer and highlights the re-emergence of concerns online about Gardasil, and its alleged mortality rate.
AI Meets Gene Editing: the Path to Plug-and-Play Drug Development
AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process. The post AI Meets Gene Editing: the Path to Plug-and-Play Drug Development appeared first on MedCity News.
Novavax Sees Sanofi Vaccine Pact as Model for Future Deals, Some Going Beyond Infectious Disease
Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said. The post Novavax Sees Sanofi…
Poll: Trust and Confidence in the CDC Remain at Low Point After Changes to Recommended Childhood Vaccines; More Say the Changes Will Hurt than Help Children’s Health
In the weeks after the Trump administration reduced the number of recommended childhood vaccines for routine use, the public’s trust in the CDC remains at its lowest point. Among those who have heard about the recent changes to the recommended childhood vaccine schedule, more say they expect the changes to have a negative impact than…
An Update on PEPFAR Reauthorization
This Policy Watch provides an update on the status of PEPFAR reauthorization, which expired on March 25, 2025, allowing certain provisions to lapse.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
[Sponsored] In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation. The post The Power of One: Redefining Healthcare with an AI-Driven Unified Platform appeared first on MedCity News.